Skip to main content
OpenTrials

Clinical trial condition

Amyloidosis, Familial

Explore clinical trials studying Amyloidosis, Familial. Study availability and eligibility vary by location and protocol.

131 public trials 53 recruiting studies
Refine in advanced search Browse all conditions

Amyloidosis, Familial trial results

Completed

Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy (TTR FAP)

NCT01705626

Conditions
Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, +33 more
Locations
  • Klinikum Wels-Grieskirchen GmbH, Abteilung für Neurologie Wels, Austria
  • University of Pécs, Department of Neurology Pécs, Hungary
  • University of Szeged, Department of Neurology Szeged, Hungary
  • University Hospital Skopje, Department of Neurology Skopje, North Macedonia
View Trial Details
Completed

Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy

NCT01737398

Conditions
Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, +16 more
Locations
  • University of California, Irvine Orange, California, United States
  • Indiana University School of Medicine Indianapolis, Indiana, United States
  • Johns Hopkins University Bayview Medical Center Baltimore, Maryland, United States
  • Boston University School of Medicine - Amyloid Treatment & Research Program Boston, Massachusetts, United States
View all 24 locations
View Trial Details
Completed

Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy

NCT01994889

Conditions
Alzheimer Disease, Amyloid Neuropathies, Amyloid Neuropathies, Familial, +20 more
Locations
  • The Kirklin Clinic Birmingham, Alabama, United States
  • UAB Hospital Department of Pharmacy IDS Birmingham, Alabama, United States
  • University Hospital, University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Arizona - Mayo Clinic Speciality Building Phoenix, Arizona, United States
View all 80 locations
View Trial Details
Completed

The Study of an Investigational Drug, Revusiran (ALN-TTRSC), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Whose Disease Has Continued to Worsen Following Liver Transplant

NCT02595983

Conditions
ATTR Amyloidosis, Amyloid Neuropathies, Amyloid Neuropathies, Familial, +16 more
Locations
  • Clinical Trial SIte Paris, France
  • Clinical Trial SIte Münster, Germany
  • Clinical Trial SIte Porto, Portugal
  • Clinical Trial SIte Majorca, Spain
View Trial Details
Completed

An Extension of Study Fx-005 Evaluating Long-Term Safety And Clinical Outcomes Of Fx-1006A In Patients With Transthyretin Amyloid Polyneuropathy

NCT00791492

Conditions
ATTR-PN, Alzheimer Disease, Amyloid Neuropathies, +22 more
Locations
  • FLENI Departamento de Hepatología y Transplante de Organos Buenos Aires, Argentina
  • FLENI-Hepatology and Organ Transplant Dept. Ciudad de Buenos Aires, Argentina
  • Hospital Universitario Clementino Fraga Filho Rio de Janeiro, Brazil
  • Service de Neurologie, CHU Henri Mondor Paris, France
View Trial Details

Related conditions